Pharmacologic augmentation of hypoxia-inducible factor-1alpha with mimosine boosts the bactericidal capacity of phagocytes.
暂无分享,去创建一个
[1] S. Normark,et al. Capsule and d‐alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps , 2007, Cellular microbiology.
[2] Ramy K. Aziz,et al. DNase Expression Allows the Pathogen Group A Streptococcus to Escape Killing in Neutrophil Extracellular Traps , 2006, Current Biology.
[3] Erwin G. Van Meir,et al. Hypoxia inducible factor-1: a novel target for cancer therapy , 2005, Anti-cancer drugs.
[4] K. Garber. New drugs target hypoxia response in tumors. , 2005, Journal of the National Cancer Institute.
[5] V. Nizet,et al. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity , 2005, The Journal of experimental medicine.
[6] V. Nizet,et al. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. , 2005, The Journal of clinical investigation.
[7] H. Malech,et al. HIF-1α: a master regulator of innate host defenses? , 2005 .
[8] C. Print,et al. Hypoxia-induced neutrophil survival is mediated by HIF-1α–dependent NF-κB activity , 2005, The Journal of experimental medicine.
[9] A. Zychlinsky,et al. Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.
[10] R. Strieter. Mastering innate immunity , 2003, Nature Medicine.
[11] R. Jaenisch,et al. HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation , 2003, Cell.
[12] J. Musser,et al. Murine model of cutaneous infection with gram-positive cocci , 1992, Infection and immunity.
[13] J. Brock,et al. The effect of synthetic iron chelators on bacterial growth in human serum. , 1988, FEMS microbiology immunology.